Functional characterization of selected differentially methylated genes
| Functionality of genes/gene names . | IGHV mutated . | IGHV unmutated . | IGHV3-21 . | Implicated role in cancer . | Accession number . | Reference . |
|---|---|---|---|---|---|---|
| IGHV mutated and IGHV unmutated CLL | ||||||
| Tumor-suppressor genes | ||||||
| ABI3* | Unmethylated | Methylated | Lost in cancer cell lines, implicated in lung metastasis | NM_016428.3 | 17 | |
| SCGB2A1* | Unmethylated | Methylated | Methylated in lung cancer | NM_002407.1 | 18 | |
| VHL | Unmethylated | Methylated | Mutated in sporadic cell renal carcinoma and von Hippel-Lindau syndrome | NT_022517.17 | 19 | |
| PPP1R3A* | Methylated | Unmethylated | Deregulated in colorectal cancer | NM_002711.2 | 20 | |
| WISP3 | Methylated | Unmethylated | Loss of expression in inflammatory breast cancer | NM_003880.2 | 21 | |
| Genes enhancing proliferation | ||||||
| ADORA3 | Methylated | Unmethylated | Activation of the NFκB pathway | NM_020683.5 | 22 | |
| AIRE | Methylated | Unmethylated | Regulated by the PKC pathway | NM_000383.1 | 23 | |
| CARD15 | Methylated | Unmethylated | Activation of the NFκB pathway | NM_022162.1 | 24 | |
| FABP7 | Methylated | Unmethylated | Regulated by the MAPK/ERK pathway | NM_001446.3 | 25 | |
| LOC340061 | Methylated | Unmethylated | Activation of the NFκB pathway | NM_198282.1 | 26 | |
| PRF1 | Methylated | Unmethylated | Enhancing the MAPK pathway | NM_005041.3 | 27 | |
| UNC5CL | Methylated | Unmethylated | Activation of the NFκB pathway | NM_173561.1 | 28 | |
| Genes facilitating tumorigenesis | ||||||
| ANGPT2 | Methylated | Unmethylated | Preferentially expressed in unmutated CLL | NM_001147.1 | 29 | |
| IFNB1 | Methylated | Unmethylated | Shown to enhance B-cell proliferation | NM_002176.2 | 30 | |
| URP2 | Methylated | Unmethylated | Implicated in facilitating CLL tumorigenesis | NM_031471.4 | 31 | |
| Antiapoptotic genes | ||||||
| BCL2 | Methylated | Unmethylated | Known antiapoptotic gene, up-regulated in many cancers | NT_025028.13 | 32 | |
| PLD1 | Unmethylated | Methylated | Stimulates cell-cycle progression by repressing p53 regulation of p21 | NM_002662.2 | 33 | |
| Proapoptotic genes | ||||||
| BCL10 | Unmethylated | Methylated | Proapoptotic genes, involved in p53 mediated cell death | NM_003921.2 | 34 | |
| IL19 | Methylated | Unmethylated | Regulating apoptosis by activation of the STAT3 pathway | NM_013371.2 | 35 | |
| Genes involved in prognosis | ||||||
| NGFR | Unmethylated | Methylated | Highly expressed in favorable prognostic ALL patients | NM_002507.1 | 36 | |
| IGHV unmutated and IGHV3-21 CLL | ||||||
| Tumor-suppressor genes | ||||||
| ABI3* | Methylated | Unmethylated | Lost in cancer cell lines, implicated in lung metastasis | NM_016428.3 | 17 | |
| GPX3 | Methylated | Unmethylated | Deleted or methylated in prostate cancer | NM_002084.2 | 37 | |
| IGSF4* | Methylated | Unmethylated | Down-regulated by methylation in neuroblastoma | NM_014333.2 | 38 | |
| SERPIND5* | Methylated | Unmethylated | Tumor-suppressive properties in breast cancer | NM_002639.2 | 39 | |
| SLC22A18 | Unmethylated | Methylated | Deregulated in several cancer forms | NM_183233.1 | 40 | |
| Genes repressing proliferation | ||||||
| LDOC1 | Unmethylated | Methylated | Implicated in repressing the NFκB pathway | NM_012317.2 | 41 | |
| ZNF540 | Methylated | Unmethylated | Involved in down-regulating the MAPK pathway | NM_152606.2 | 42 | |
| Genes facilitating tumorigenesis | ||||||
| IL17RC | Unmethylated | Methylated | Shown to facilitate tumorigenesis in prostate cancer | NM_032732.2 | 43 | |
| ANGPT2 | Unmethylated | Methylated | Expressed in IGHV unmutated CLL | NM_001147.1 | 29 | |
| FHL2 | Methylated | Unmethylated | NM_201556.1 | |||
| S100A14 | Unmethylated | Methylated | NM_020672.1 | |||
| Antiapoptotic genes | ||||||
| BCL2 | Unmethylated | Methylated | Known antiapoptotic gene, up-regulated in many cancers | NT_025028.13 | 32 | |
| PLD1 | Methylated | Unmethylated | Stimulates cell-cycle progression by repressing p53 regulation of p21 | NM_002662.2 | 33 | |
| IGHV mutated and IGHV3-21 CLL | ||||||
| Genes enhancing proliferation | ||||||
| LOC340061 | Methylated | Unmethylated | Activation of the NFκB pathway | NM_198282.1 | 26 | |
| PRF1 | Methylated | Unmethylated | Enhancing the MAPK pathway | NM_005041.3 | 27 | |
| RASGRP3 | Methylated | Unmethylated | Regulated B-cell proliferation by facilitating B-cell receptor–RAS signaling | NM_170672.1 | 44 | |
| Genes facilitating tumorigenesis | ||||||
| LMO2 | Methylated | Unmethylated | Known proto-oncogene, expressed in human B-cell lymphomas | NM_005574.2 | 45 | |
| URP2 | Methylated | Unmethylated | Implicated in facilitating CLL tumorgenesis | NM_031471.4 | 31 | |
| NCRMS | Methylated | Unmethylated | XR_000219.2 | |||
| Proapoptotic genes | ||||||
| TP53I3 | Methylated | Unmethylated | Shown to induce p53-mediated cell death | NM_004881.2 | 46 | |
| BCL10 | Unmethylated | Methylated | Proapoptotic genes, involved in p53-mediated cell death | NM_003921.2 | 34 | |
| Genes involved in prognosis | ||||||
| DNTT | Methylated | Unmethylated | Associated with poor prognosis in acute myeloid leukemia | NM_004088.3 | 47 |
| Functionality of genes/gene names . | IGHV mutated . | IGHV unmutated . | IGHV3-21 . | Implicated role in cancer . | Accession number . | Reference . |
|---|---|---|---|---|---|---|
| IGHV mutated and IGHV unmutated CLL | ||||||
| Tumor-suppressor genes | ||||||
| ABI3* | Unmethylated | Methylated | Lost in cancer cell lines, implicated in lung metastasis | NM_016428.3 | 17 | |
| SCGB2A1* | Unmethylated | Methylated | Methylated in lung cancer | NM_002407.1 | 18 | |
| VHL | Unmethylated | Methylated | Mutated in sporadic cell renal carcinoma and von Hippel-Lindau syndrome | NT_022517.17 | 19 | |
| PPP1R3A* | Methylated | Unmethylated | Deregulated in colorectal cancer | NM_002711.2 | 20 | |
| WISP3 | Methylated | Unmethylated | Loss of expression in inflammatory breast cancer | NM_003880.2 | 21 | |
| Genes enhancing proliferation | ||||||
| ADORA3 | Methylated | Unmethylated | Activation of the NFκB pathway | NM_020683.5 | 22 | |
| AIRE | Methylated | Unmethylated | Regulated by the PKC pathway | NM_000383.1 | 23 | |
| CARD15 | Methylated | Unmethylated | Activation of the NFκB pathway | NM_022162.1 | 24 | |
| FABP7 | Methylated | Unmethylated | Regulated by the MAPK/ERK pathway | NM_001446.3 | 25 | |
| LOC340061 | Methylated | Unmethylated | Activation of the NFκB pathway | NM_198282.1 | 26 | |
| PRF1 | Methylated | Unmethylated | Enhancing the MAPK pathway | NM_005041.3 | 27 | |
| UNC5CL | Methylated | Unmethylated | Activation of the NFκB pathway | NM_173561.1 | 28 | |
| Genes facilitating tumorigenesis | ||||||
| ANGPT2 | Methylated | Unmethylated | Preferentially expressed in unmutated CLL | NM_001147.1 | 29 | |
| IFNB1 | Methylated | Unmethylated | Shown to enhance B-cell proliferation | NM_002176.2 | 30 | |
| URP2 | Methylated | Unmethylated | Implicated in facilitating CLL tumorigenesis | NM_031471.4 | 31 | |
| Antiapoptotic genes | ||||||
| BCL2 | Methylated | Unmethylated | Known antiapoptotic gene, up-regulated in many cancers | NT_025028.13 | 32 | |
| PLD1 | Unmethylated | Methylated | Stimulates cell-cycle progression by repressing p53 regulation of p21 | NM_002662.2 | 33 | |
| Proapoptotic genes | ||||||
| BCL10 | Unmethylated | Methylated | Proapoptotic genes, involved in p53 mediated cell death | NM_003921.2 | 34 | |
| IL19 | Methylated | Unmethylated | Regulating apoptosis by activation of the STAT3 pathway | NM_013371.2 | 35 | |
| Genes involved in prognosis | ||||||
| NGFR | Unmethylated | Methylated | Highly expressed in favorable prognostic ALL patients | NM_002507.1 | 36 | |
| IGHV unmutated and IGHV3-21 CLL | ||||||
| Tumor-suppressor genes | ||||||
| ABI3* | Methylated | Unmethylated | Lost in cancer cell lines, implicated in lung metastasis | NM_016428.3 | 17 | |
| GPX3 | Methylated | Unmethylated | Deleted or methylated in prostate cancer | NM_002084.2 | 37 | |
| IGSF4* | Methylated | Unmethylated | Down-regulated by methylation in neuroblastoma | NM_014333.2 | 38 | |
| SERPIND5* | Methylated | Unmethylated | Tumor-suppressive properties in breast cancer | NM_002639.2 | 39 | |
| SLC22A18 | Unmethylated | Methylated | Deregulated in several cancer forms | NM_183233.1 | 40 | |
| Genes repressing proliferation | ||||||
| LDOC1 | Unmethylated | Methylated | Implicated in repressing the NFκB pathway | NM_012317.2 | 41 | |
| ZNF540 | Methylated | Unmethylated | Involved in down-regulating the MAPK pathway | NM_152606.2 | 42 | |
| Genes facilitating tumorigenesis | ||||||
| IL17RC | Unmethylated | Methylated | Shown to facilitate tumorigenesis in prostate cancer | NM_032732.2 | 43 | |
| ANGPT2 | Unmethylated | Methylated | Expressed in IGHV unmutated CLL | NM_001147.1 | 29 | |
| FHL2 | Methylated | Unmethylated | NM_201556.1 | |||
| S100A14 | Unmethylated | Methylated | NM_020672.1 | |||
| Antiapoptotic genes | ||||||
| BCL2 | Unmethylated | Methylated | Known antiapoptotic gene, up-regulated in many cancers | NT_025028.13 | 32 | |
| PLD1 | Methylated | Unmethylated | Stimulates cell-cycle progression by repressing p53 regulation of p21 | NM_002662.2 | 33 | |
| IGHV mutated and IGHV3-21 CLL | ||||||
| Genes enhancing proliferation | ||||||
| LOC340061 | Methylated | Unmethylated | Activation of the NFκB pathway | NM_198282.1 | 26 | |
| PRF1 | Methylated | Unmethylated | Enhancing the MAPK pathway | NM_005041.3 | 27 | |
| RASGRP3 | Methylated | Unmethylated | Regulated B-cell proliferation by facilitating B-cell receptor–RAS signaling | NM_170672.1 | 44 | |
| Genes facilitating tumorigenesis | ||||||
| LMO2 | Methylated | Unmethylated | Known proto-oncogene, expressed in human B-cell lymphomas | NM_005574.2 | 45 | |
| URP2 | Methylated | Unmethylated | Implicated in facilitating CLL tumorgenesis | NM_031471.4 | 31 | |
| NCRMS | Methylated | Unmethylated | XR_000219.2 | |||
| Proapoptotic genes | ||||||
| TP53I3 | Methylated | Unmethylated | Shown to induce p53-mediated cell death | NM_004881.2 | 46 | |
| BCL10 | Unmethylated | Methylated | Proapoptotic genes, involved in p53-mediated cell death | NM_003921.2 | 34 | |
| Genes involved in prognosis | ||||||
| DNTT | Methylated | Unmethylated | Associated with poor prognosis in acute myeloid leukemia | NM_004088.3 | 47 |
These genes represent candidate tumor-suppressor genes.